US GAO Review Of FDA’s OTC Drug Oversight Signals Waiting For Monograph Reform Benefits
Executive Summary
Benefits of OTC monograph reform legislation passed in March likely will take at least several years, according to GAO report to Congress. It notes the FDA still is analyzing the legislation and it may need two years to add and train staff.